Currently out of the existing stock ratings of Olivia Brayer, 76 are a BUY (64.96%), 41 are a HOLD (35.04%).

Olivia Brayer

Work Performance Price Targets & Ratings Chart

Analyst Olivia Brayer, currently employed at BAIRD, carries an average stock price target met ratio of 58.33% that have a potential upside of 30.97% achieved within 123 days. Previously, Olivia Brayer worked at CANTOR FITZGERALD, BAML.

Olivia Brayer’s has documented 231 price targets and ratings displayed on 16 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on INSM, Insmed at 10-Jun-2026.

Wall Street Analyst Olivia Brayer

Analyst best performing recommendations are on CTMX (CYTOMX THERAPEUTICS).
The best stock recommendation documented was for BMY (BRISTOL-MYERS SQUIBB COMPANY) at 7/22/2024. The price target of $45 was fulfilled within 4 days with a profit of $6.11 (15.71%) receiving and performance score of 39.28.

Average potential price target upside

ALNY Alnylam Pharmaceuticals AMGN Amgen AUPH Aurinia Pharmaceuticals BMRN Biomarin Pharmaceutical BMY Bristol-Myers Squibb Company CTMX CytomX Therapeutics GILD Gilead Sciences GRPH Graphite Bio MNKD MannKind Corp REGN Regeneron Pharmaceuticals UTHR United Therapeutics VNDA Vanda Pharmaceuticals VRNA Verona Pharma PLC ADR VRTX Vertex Pharmaceuticals GOSS Gossamer Bio INSM Insmed

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 10-Oct-2021

$354

$122.17 (52.70%)

$475

8 days ago
(15-Oct-2026)

6/7 (85.71%)

$119.97 (51.26%)

211

Buy Since 19-May-2026

$320

$88.17 (38.03%)

$340

9 days ago
(14-Oct-2026)

0/3 (0%)

$95.53 (42.56%)

Hold Since 20-Oct-2025

$253

$21.17 (9.13%)

$256

9 days ago
(14-Oct-2026)

2/7 (28.57%)

$28.53 (12.71%)

38

Buy Since 20-Sep-2022

$345

$113.17 (48.82%)

$350

15 days ago
(08-Oct-2026)

31/38 (81.58%)

$120.47 (53.65%)

180

Buy Since 15-May-2025

$369

$137.17 (59.17%)

$375

23 days ago
(30-Sep-2026)

9/12 (75%)

$122.26 (49.55%)

30

Show more analysts

Please expand the browser size to see the chart

Which stock is Olivia Brayer most bullish on?

Potential upside of $140.96 has been obtained for INSM (INSMED)

What Year was the first public recommendation made by Olivia Brayer?

On 2021
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?